Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells
- 1 June 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (11) , 1719-1724
- https://doi.org/10.1016/s0006-2952(97)00016-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Melanocyte Differentiation Marker gp75, the Brown Locus Protein, Can Be Regulated Independently of Tyrosinase and PigmentationJournal of Investigative Dermatology, 1995
- Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.Molecular and Cellular Biology, 1994
- Expression Studies of Pigmentation and POU‐Domain Genes in Human Melanoma CellsPigment Cell Research, 1994
- Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cellsBiochemical Pharmacology, 1994
- Automated cycle sequencing of PCR templates: Relationships between fragment size, concentration and strand renaturation rates on sequencing efficiencyDNA Sequence, 1994
- A transcriptionally active DNA-binding site for human p53 protein complexes.Molecular and Cellular Biology, 1992
- Biosynthesis and intracellular movement of the melanosomal membrane glycoprotein gp75, the human b (brown) locus productExperimental Cell Research, 1991
- In Vitro Phenotypic Alteration of Human Melanoma Cells Induced by Differentiating Agents: Heterogeneous Effects on Cellular Growth and Morphology, Enzymatic Activity, and Antigenic ExpressionPigment Cell Research, 1990
- Monoclonal Antibody Against Human Tyrosine and Reactive With Melanotic and Amelanotic Melanoma CellsJournal of Investigative Dermatology, 1988
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.The Journal of cell biology, 1988